15-Year watch: tracking blood cancer patients after revolutionary cell therapy
Disease control
Recruiting now
This study follows 546 patients who received Galapagos CAR T-cell therapies for blood cancers to monitor their health for 15 years after treatment. Researchers will track long-term safety, check if the treatment cells remain in the body, and watch for any delayed side effects. Th…
Phase: PHASE3 • Sponsor: Galapagos NV • Aim: Disease control
Last updated Apr 02, 2026 00:56 UTC